Haval Balata
- Accuracy of "pulmonary fibrosis" diagnosis on death certificates - All scarring isn't IPFBy Haval Balata, Sheila Grecian, Robert Grecian, Sheila Augustine, Imran Aziz and Abdul AshishHaval Balata1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomSheila Grecian1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomRobert Grecian1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomSheila Augustine1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomImran Aziz1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomAbdul Ashish1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United Kingdom
- The relationship between social deprivation and hospital admissions with asthmaBy Sheila Grecian, Robert Grecian, Sandra Dermott, Haval Balata, Abdul Ashish and Imran AzizSheila Grecian1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomRobert Grecian1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomSandra Dermott1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomHaval Balata1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomAbdul Ashish1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomImran Aziz1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United Kingdom
- Hospital readmissions and social deprivation in asthma and COPDBy Haval Balata, Robert Grecian, Sheila Grecian, Imran Aziz and Abdul AshishHaval Balata1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomRobert Grecian1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomSheila Grecian1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomImran Aziz1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United KingdomAbdul Ashish1Respiratory Medicine, Royal Albert Edward Infirmary, Wigan, United Kingdom
- Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines?By Haval Balata, Matthew Evison, Haider Al-Najjar, Phil Barber, Richard Booton and Philip CrosbieHaval Balata1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United KingdomMatthew Evison1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United Kingdom2The University of Manchester, The University of Manchester, Manchester, United KingdomHaider Al-Najjar1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United KingdomPhil Barber1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United KingdomRichard Booton1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United Kingdom2The University of Manchester, The University of Manchester, Manchester, United KingdomPhilip Crosbie1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United Kingdom2The University of Manchester, The University of Manchester, Manchester, United Kingdom
- Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patientsBy Haval Balata, Matthew Evison, Julie Morris, Haider Al-Najjar, Phil Barber, Philip Crosbie and Richard BootonHaval Balata1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United KingdomMatthew Evison1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United Kingdom2The University of Manchester, The University of Manchester, Manchester, United KingdomJulie Morris3Department of Medical Statistics, University Hospital of South Manchester, Manchester, United KingdomHaider Al-Najjar1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United KingdomPhil Barber1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United KingdomPhilip Crosbie1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United Kingdom2The University of Manchester, The University of Manchester, Manchester, United KingdomRichard Booton1Manchester Thoracic Oncology Centre, University Hospital South Manchester, Manchester, United Kingdom2The University of Manchester, The University of Manchester, Manchester, United Kingdom
- Validation of a risk stratification model for patients with isolated mediastinal/hilar lymphadenopathy (IMHL) and a negative EBUSBy Haider Al-Najjar, Matthew Evison, Julie Morris, Julie Martin, Haval Balata, Philip Barber, Richard Booton and Philip CrosbieHaider Al-Najjar1Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Manchester, United KingdomMatthew Evison1Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Manchester, United Kingdom2The Institute of Inflammation and Repair, The University of Manchester, Manchester, United KingdomJulie Morris3Department of Medical Statistics, University Hospital of South Manchester, Manchester, United KingdomJulie Martin1Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Manchester, United KingdomHaval Balata1Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Manchester, United KingdomPhilip Barber1Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Manchester, United KingdomRichard Booton1Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Manchester, United Kingdom2The Institute of Inflammation and Repair, The University of Manchester, Manchester, United KingdomPhilip Crosbie1Manchester Thoracic Oncology Centre, University Hospital of South Manchester, Manchester, United Kingdom2The Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom
- Should resection rate increase when PET-CT use increases? An analysis of PET-CT use in large UK lung cancer network 2011 - 2013By Haval Balata, Evison Matthew, Julie Morris, Haider Al-Najjar, Phil Barber, Philip Crosbie and Richard BootonHaval Balata1Manchester Thoracic Oncology Unit, University Hospital South Manchester, Manchester, United KingdomEvison Matthew1Manchester Thoracic Oncology Unit, University Hospital South Manchester, Manchester, United Kingdom2University of Manchester, Oxford Road, Manchester, United KingdomJulie Morris1Manchester Thoracic Oncology Unit, University Hospital South Manchester, Manchester, United KingdomHaider Al-Najjar1Manchester Thoracic Oncology Unit, University Hospital South Manchester, Manchester, United KingdomPhil Barber1Manchester Thoracic Oncology Unit, University Hospital South Manchester, Manchester, United KingdomPhilip Crosbie1Manchester Thoracic Oncology Unit, University Hospital South Manchester, Manchester, United Kingdom2University of Manchester, Oxford Road, Manchester, United KingdomRichard Booton1Manchester Thoracic Oncology Unit, University Hospital South Manchester, Manchester, United Kingdom2University of Manchester, Oxford Road, Manchester, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.